ROLE OF CYCLIC-AMP IN CARDIAC BETA-ADRENOCEPTOR DESENSITIZATION - STUDIES USING PRENALTEROL AND INHIBITORS OF PHOSPHODIESTERASE

被引:15
作者
BOBIK, A
LITTLE, PJ
机构
[1] ALFRED HOSP, BAKER MED RES INST, PRAHRAN, VIC 3181, AUSTRALIA
[2] ALFRED HOSP, CLIN RES UNIT, PRAHRAN, VIC 3181, AUSTRALIA
关键词
D O I
10.1097/00005344-198409000-00009
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The effects of prolonged exposure of cardiac cells in primary culture to the partial .beta.-adrenoceptor agonist prenalterol and inhibitors of phosphodiesterase on their subsequent ability to increase intracellular cAMP during a 5-min exposure to 50 .mu.M isoprenaline (receptor responsiveness) was studied. Although prenalterol possesses 7% of the agonist activity of isoprenaline on adenylate cyclase, it induces extensive .beta.-adrenoceptor desensitization. After exposing the cells to 1 .mu.M prenalterol for 3 h, .beta.-adrenoceptor responsiveness was reduced 40% (P < 0.05): after 12 h the reduction averaged 55%. Prolonging the incubation time to 48 h had no further effect on receptor desensitization. The desensitization magnitude was concentration dependent. Cells to exposed 10-8 M prenalterol for 16 h, reduced receptor responsiveness was by 19%, and at concentrations of 1 .mu.M and higher reduced responsiveness by 60% (P < 0.01). Receptor desensitization appeared to be due to an inability of receptors to activate adenylate cyclase as well as to receptor loss. To investigate if .beta.-adrenoceptor desensitization and receptor loss could be mediated by cAMP, the cells were exposed for 16 h to phosphodiesterase inhibitors. Cells exposed to the phosphodiesterase inhibitor isobutylmethylxanthine (0.1 mM) (which increased intracellular cAMP by between 50 and 150%) also induced receptor desensitization. Reduction in receptor responsiveness averaged 62% (P < 0.01). The responsiveness loss could be due by to an inability of receptors to activate adenylate cyclase was by receptor loss. .beta.-Adrenoceptor numbers were reduced by 24% (P < 0.025). A similar reduction in receptor numbers could be induced by exposing the cells to the phosphodiesterase inhibitor ICI 63197 (0.5 mM). In both instances, the affinity of the .beta.-adrenoceptor for the radioligand [125I]iodocyanopindolol was unaltered. .beta.-Adrenoceptor-induced desensitization of cardiac .beta.-adrenoceptors is due to an inability of receptors to activate adenylate cyclase and to an apparent loss of membrane receptors.
引用
收藏
页码:795 / 801
页数:7
相关论文
共 25 条
  • [2] MECHANISM OF ISOPRENALINE-INDUCED REFRACTORINESS OF THE BETA-ADRENOCEPTOR-ADENYLATE CYCLASE SYSTEM IN CHICK-EMBRYO CARDIAC-CELLS
    BOBIK, A
    CAMPBELL, JH
    CARSON, V
    CAMPBELL, GR
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1981, 3 (03) : 541 - 553
  • [3] THE EFFECTS OF ENDOGENOUS PHOSPHOLIPASE-A2 ACTIVATION ON BETA-ADRENOCEPTOR FUNCTION IN CARDIAC-CELLS
    BOBIK, A
    CAMPBELL, J
    SNOW, P
    LITTLE, PJ
    [J]. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1983, 15 (11) : 759 - 767
  • [4] DECREASED CATECHOLAMINE SENSITIVITY AND BETA-ADRENERGIC-RECEPTOR DENSITY IN FAILING HUMAN HEARTS
    BRISTOW, MR
    GINSBURG, R
    MINOBE, W
    CUBICCIOTTI, RS
    SAGEMAN, WS
    LURIE, K
    BILLINGHAM, ME
    HARRISON, DC
    STINSON, EB
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1982, 307 (04) : 205 - 211
  • [5] DECREASED LYMPHOCYTE BETA-ADRENERGIC-RECEPTOR DENSITY IN PATIENTS WITH HEART-FAILURE AND TOLERANCE TO THE BETA-ADRENERGIC AGONIST PIRBUTEROL
    COLUCCI, WS
    ALEXANDER, RW
    WILLIAMS, GH
    RUDE, RE
    HOLMAN, BL
    KONSTAM, MA
    WYNNE, J
    MUDGE, GH
    BRAUNWALD, E
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1981, 305 (04) : 185 - 190
  • [6] HEDBERG A, 1981, J PHARMACOL EXP THER, V219, P798
  • [7] HONERJAGER P, 1981, N-S ARCH PHARMACOL, V318, P112
  • [8] CARDIOSELECTIVITY OF PRENALTEROL AND ISOPROTERENOL
    JENNINGS, G
    BOBIK, A
    ODDIE, C
    HARGREAVES, M
    KORNER, P
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1983, 34 (06) : 749 - 757
  • [9] KENAKIN TP, 1980, J PHARMACOL EXP THER, V213, P406
  • [10] EFFECTS OF INVIVO BETA-ADRENOCEPTOR DOWN-REGULATION ON CARDIAC RESPONSES TO PRENALTEROL AND PIRBUTEROL
    KENAKIN, TP
    FERRIS, RM
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1983, 5 (01) : 90 - 97